Selected article for: "disease research and infectious disease research"
Author: Turnquist, Casmir; Ryan, Bríd M.; Horikawa, Izumi; Harris, Brent T.; Harris, Curtis C.
Title: Cytokine Storms in Cancer and COVID-19
  • Cord-id: 13ergctx
  • Document date: 2020_10_2
    • ID: 13ergctx
    Snippet: During the COVID-19 pandemic, research on "cytokine storms" has been reinvigorated in the field of infectious disease, but it also has particular relevance to cancer research. Interleukin-6 (IL-6) has emerged as a key component of the immune response to SARS-CoV-2, such that the repurposing of anti-IL-6 therapeutics for COVID-19 is now a major line of investigation, with several ongoing clinical trials. We lay a framework for understanding the role of IL-6 in the context of cancer research and C
    Document: During the COVID-19 pandemic, research on "cytokine storms" has been reinvigorated in the field of infectious disease, but it also has particular relevance to cancer research. Interleukin-6 (IL-6) has emerged as a key component of the immune response to SARS-CoV-2, such that the repurposing of anti-IL-6 therapeutics for COVID-19 is now a major line of investigation, with several ongoing clinical trials. We lay a framework for understanding the role of IL-6 in the context of cancer research and COVID-19 and suggest how lessons learned from cancer research may impact SARS-CoV-2 research and vice versa.

    Search related documents:
    Co phrase search for related documents
    • acute ards respiratory distress syndrome and additional trial: 1
    • acute ards respiratory distress syndrome and lung cancer: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
    • acute ards respiratory distress syndrome and lung cancer case: 1
    • acute ards respiratory distress syndrome and lung cancer patient: 1
    • acute ards respiratory distress syndrome and lung cancer risk: 1, 2, 3, 4, 5, 6, 7
    • acute lymphoblastic leukemia and liver cancer: 1
    • liver cancer and lung cancer: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • liver cancer and lung cancer case: 1
    • liver cancer and lung cancer focus: 1
    • liver cancer and lung cancer proliferation: 1
    • liver cancer and lung cancer risk: 1, 2, 3